Christopher Downs - 06 Dec 2021 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Chief Financial Officer
Signature
/s/ Christopher Downs
Issuer symbol
CNSP
Transactions as of
06 Dec 2021
Net transactions value
+$4,702
Form type
4
Filing time
07 Dec 2021, 07:30:08 UTC
Previous filing
22 Nov 2021
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $4,702 +5,000 +3.4% $0.9403 151,500 06 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.9400 to $0.947299. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.